Technology, billing, regulations—how do rheumatologists manage the business side of their practices in an ever-changing environment? During this year’s Annual Meeting, a practical, full-day workshop will offer attendees the tools to thrive in today’s healthcare business landscape…
Considering an Investment in a Healthcare Tech Startup? 5 Tips
Investing in a healthcare tech startup can be tempting for rheumatologists looking for a change of pace. Here are a few insights on the risks and benefits of investing…
Roche & Novartis Face Off in Biosimilar Drug Battle
ZURICH (Reuters)—Switzerland’s biggest drugmakers are clashing over cheaper copies of pricey biotech drugs—one reason why Novartis is considering selling its $14 billion stake in cross-town rival Roche. With a copycat of Roche’s blood cancer drug Rituxan (rituximab) pending European approval, Novartis aims to muscle in on a share of sales that last year hit 7…
Advertise This
Medical marketing is an interesting place; beware inaccurate claims